Physician profile
Scott Brian Hanauer
NPI 1922599554
$73,087.41
in general payments reported to CMS, 2019-2025
31 companies · $55K in 2025
The $55K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,462 · 2022: $6,569 · 2023: $864 · 2024: $8,739 · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $5,472 · Travel and Lodging: $3,349 · Education: $86.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $46,149.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $5,471.84 |
| Travel and Lodging | $3,348.84 |
| Education | $86.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $43,942.07 | 2022-2025 | |
| Arthrex, INC. | $10,319.99 | 2022-2025 | Distal Extremities Implants Foot & Ankle Bunion |
| Forma Medical | $7,880.12 | 2025 | Optimalmtp |
| Seapearl East, INC | $6,425.23 | 2022-2025 | |
| Stryker Corporation | $1,991.67 | 2021-2025 | Prophecy, Ortholoc 2 Lapifuse, Augment Injectable |
| Paragon 28, INC. | $317.67 | 2021-2023 | Monkey Rings |
| Biotronik Nro, INC. | $240.10 | 2023-2025 | Prospera, Biotronik |
| Tersera Therapeutics LLC | $218.80 | 2024-2025 | Prialt |
| Medtronic, INC. | $218.58 | 2022-2024 | Intellis Adaptivestim |
| Curonix LLC | $205.49 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $169.17 | 2023-2024 | Evoke, Evoke Scs |
| Vertos Medical, INC. | $167.90 | 2022 | |
| Scilex Pharmaceuticals INC. | $146.11 | 2023-2025 | Ztlido |
| Averitas Pharma INC. | $111.21 | 2023-2025 | Qutenza |
| Maxx Health INC | $110.83 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novastep INC. | $110.64 | 2022 | |
| Zimmer Biomet Holdings, INC. | $97.93 | 2022 | |
| Smith+Nephew, INC. | $96.96 | 2021-2025 | Stravix Pl, Lens 4k |
| Fusion Orthopedics USA, LLC | $87.27 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.33 | 2022-2023 | Relistor |
| Nevro Corp. | $30.03 | 2022 | |
| Zimvie INC. | $24.58 | 2022 | |
| Bioventus LLC | $21.08 | 2022 | |
| Depuy Synthes Sales INC. | $19.18 | 2024 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $17.13 | 2025 | |
| Globus Medical, INC. | $16.67 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $14.19 | 2023 | Seglentis |
| Collegium Pharmaceutical, INC. | $14.10 | 2025 | Xtampza |
| Paratek Pharmaceuticals, INC. | $12.85 | 2023 | Nuzyra |
| Integra Lifesciences Corporation | $12.17 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $4.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hanauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.